These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9643008)

  • 1. [Characterization of amyloid beta protein species in the plasma, cerebrospinal fluid and brains of patients with Alzheimer's disease].
    Tamaoka A
    Nihon Ronen Igakkai Zasshi; 1998 Apr; 35(4):273-7. PubMed ID: 9643008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.
    Tamaoka A; Fukushima T; Sawamura N; Ishikawa K; Oguni E; Komatsuzaki Y; Shoji S
    J Neurol Sci; 1996 Sep; 141(1-2):65-8. PubMed ID: 8880695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
    Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.
    Tamaoka A; Sawamura N; Fukushima T; Shoji S; Matsubara E; Shoji M; Hirai S; Furiya Y; Endoh R; Mori H
    J Neurol Sci; 1997 May; 148(1):41-5. PubMed ID: 9125389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases.
    Barelli H; Lebeau A; Vizzavona J; Delaere P; Chevallier N; Drouot C; Marambaud P; Ancolio K; Buxbaum JD; Khorkova O; Heroux J; Sahasrabudhe S; Martinez J; Warter JM; Mohr M; Checler F
    Mol Med; 1997 Oct; 3(10):695-707. PubMed ID: 9392006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene.
    Ishii K; Ii K; Hasegawa T; Shoji S; Doi A; Mori H
    Neurosci Lett; 1997 May; 228(1):17-20. PubMed ID: 9197277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).
    Gravina SA; Ho L; Eckman CB; Long KE; Otvos L; Younkin LH; Suzuki N; Younkin SG
    J Biol Chem; 1995 Mar; 270(13):7013-6. PubMed ID: 7706234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
    Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
    Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37).
    Mehta PD; Blain JF; Freeman EA; Patrick BA; Barshatzky M; Hrdlicka LA; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Patzke H; Miller DL
    J Alzheimers Dis; 2017; 57(1):135-145. PubMed ID: 28222530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type-specific enhancement of amyloid-beta deposition in a novel presenilin-1 mutation (P117L).
    Wegiel J; Wisniewski HM; Kuchna I; Tarnawski M; Badmajew E; Popovitch E; Kulczycki J; Dowjat WK; Wisniewski T
    J Neuropathol Exp Neurol; 1998 Sep; 57(9):831-8. PubMed ID: 9737546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta protein 1-42/43 (A beta 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study.
    Tamaoka A; Sawamura N; Odaka A; Suzuki N; Mizusawa H; Shoji S; Mori H
    Brain Res; 1995 May; 679(1):151-6. PubMed ID: 7648258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
    Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
    Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin-1 is associated with Alzheimer's disease amyloid.
    Wisniewski T; Dowjat WK; Permanne B; Palha J; Kumar A; Gallo G; Frangione B
    Am J Pathol; 1997 Aug; 151(2):601-10. PubMed ID: 9250173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.